Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Interest Expenses (2016 - 2023)

Dexcom (DXCM) has disclosed Interest Expenses for 14 consecutive years, with $5.9 million as the latest value for Q2 2023.

  • Quarterly Interest Expenses rose 25.53% to $5.9 million in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $5.9 million through Mar 2024, down 68.28% year-over-year, with the annual reading at $18.6 million for FY2022, 1.06% down from the prior year.
  • Interest Expenses for Q2 2023 was $5.9 million at Dexcom, up from $4.6 million in the prior quarter.
  • The five-year high for Interest Expenses was $24.4 million in Q3 2020, with the low at -$42.4 million in Q4 2020.
  • Average Interest Expenses over 5 years is $7.0 million, with a median of $4.8 million recorded in 2021.
  • The sharpest move saw Interest Expenses soared 212.5% in 2019, then crashed 377.12% in 2020.
  • Over 5 years, Interest Expenses stood at $15.3 million in 2019, then plummeted by 377.12% to -$42.4 million in 2020, then surged by 111.08% to $4.7 million in 2021, then changed by 0.0% to $4.7 million in 2022, then grew by 25.53% to $5.9 million in 2023.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $5.9 million, $4.6 million, and $4.7 million for Q2 2023, Q1 2023, and Q4 2022 respectively.